4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-105512
Chief Operating Officer sold 5,270 shares at $31.89 ($168,060)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-09-11 | Sale 10b5-1 | −2,548 | $31.89 | $81,256 | 143,334 | D |
| HIGH SUSANNA GATTI Chief Operating Officer | 2024-09-11 | Sale 10b5-1 | −2,722 | $31.89 | $86,805 | 140,612 | D |
| Open-market sales · 5,270 sh · avg $31.89 · $168,060 | |||||||
Loading xslF345X05/ownership.xml…